Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Israel's Teva, US Allergan agree to pay $54 million in San Francisco opioid lawsuit | The Times of Israel
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva, Israel's Biggest Country, In Opioid Legal Trouble
Teva Pharmaceutical | PBS NewsHour
Teva Pharmaceuticals will pay $420 million in a federal case
Teva to pay $512M to resolve Provigil-delay lawsuit
Teva Stock Pressured From Antitrust Lawsuit Against Drug Makers | Barron's
New York Jury Finds Drugmaker Teva Liable for Fueling Opioid Crisis
Allergan, Teva to pay $54M in San Francisco opioid lawsuit
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Drug distributors, Teva reach tentative settlement of opioids lawsuit - STAT
Teva to pay New York $500M for role in opioid crisis - POLITICO
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
California lawsuit leads to Allergan, Teva receiving $54 million fine | Fox Business
Attorney General Morrisey sues opioid makers Johnson & Johnson, Teva Pharmaceuticals | WBOY.com
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva settles shareholder lawsuit over generic drug | Business Insurance
